Journal of Ayurveda and Integrative Medicine,
Год журнала:
2025,
Номер
16(1), С. 101041 - 101041
Опубликована: Янв. 1, 2025
Multi-targeted
drug
therapy
has
received
substantial
attention
for
the
treatment
of
diseases
multi-factorial
origin,
including
neurodegenerative
and
autoimmune
diseases.
It
seems
reasonable
to
argue
that
complex
pathology
(ND)
cannot
be
reduced
a
single
target
modulate
broad
range
cellular
signaling,
associated
pathologies,
symptoms.
is
this
idea
brought
scientific
world
towards
phytochemicals
traditional
drugs
are
notoriously
multi-targeted.
A
systematic
study
these
formulations
establishing
molecular
pathways
individual
molecules
can
lead
standardized
multi-component
product
activities
on
different
targets
ND.
This
could
provide
an
accessible
affordable
solution
significant
disease
burden
With
in
mind,
review
was
carried
out
Ayurvedic
Manasamitra
Vatakam
(MMV),
known
neuroprotective
formulation
highly
effective
against
Alzheimer's
disease.
MMV
source
phytomolecules
treating
The
multifactorial
nature
makes
them
suitable
candidates
testing
due
inherent
multitargeting
capabilities
compounds.
primary
objective
comprehensive
understanding
from
responsible
its
multitargeted
effect
From
reported
literature,
it
clear
many
phytoconstituents
extracts
herbal
ingredients
have
demonstrated
their
efficacy
AD
models.
However,
combination
models
never
been
tested.
Scientific
studies
should
done
explore
bioactive
compounds
druggability
identified
evaluated
using
experimental
methods.
Perioperative
neurocognitive
disorders
(PND)
are
the
most
common
postoperative
complications
with
few
therapeutic
options.
Gut
microbial
dysbiosis
is
associated
neurological
diseases;
however,
mechanisms
by
which
microbiota
regulates
gastrointestinal
and
cognitive
function
incompletely
understood.Behavioral
testing,
MiSeq
16S
rRNA
gene
sequencing,
non-target
metabolism,
intestinal
permeability
detection,
protein
assays,
immunofluorescence
staining
were
employed
to
discern
impacts
of
surgery
on
profiles,
barriers,
serum
brain.
Interventions
in
mice
included
fecal
transplantation,
anti-inflammatory
agent
dexamethasone,
Lactobacillus
supplementation,
indole
propionic
acid
palmitic
amide
administration.Surgery-induced
impairment
occurs
predominantly
aged
mice,
surgery-induced
alterations
composition
profile
exacerbate
barrier
disruption
mice.
These
adverse
effects
can
be
mitigated
transferring
from
young
donors
or
bolstering
using
Lactobacillus,
acid.
Moreover,
profiles
restored
transplanting
feces
surgical
improving
neuropathology
function,
these
coincide
increased
permeability.
Metabolomic
screening
identified
metabolites
mouse
after
surgery,
especially
increase
amide.
Palmitic
levels
brain
decreased
Oral
exacerbates
neuropathological
changes
mice.Gut
a
key
mechanism
leading
cognition
dysfunction,
disrupts
metabolic
abnormalities,
resulting
neuroinflammation
dendritic
spine
loss.
Intestinal
damage
high
level
old
may
cause
incidence
PND
elderly.
Preoperative
regulation
restoration
benefit
preventing
PND.
Video
Abstract.
ACS Chemical Neuroscience,
Год журнала:
2024,
Номер
15(8), С. 1712 - 1727
Опубликована: Апрель 6, 2024
Short-chain
fatty
acids
(SCFAs)
are
gut
microbial
metabolic
derivatives
produced
during
the
fermentation
of
ingested
complex
carbohydrates.
SCFAs
have
been
widely
regarded
to
a
potent
anti-inflammatory
and
neuro-protective
role
implications
in
several
disease
conditions,
such
as,
inflammatory
bowel
disease,
type-2
diabetes,
neurodegenerative
disorders.
Japanese
encephalitis
virus
(JEV),
neurotropic
flavivirus,
is
associated
with
life
threatening
neuro-inflammation
neurological
sequelae
infected
hosts.
In
this
study,
we
hypothesize
that
potential
mitigating
JEV
pathogenesis.
Postnatal
day
10
BALB/c
mice
were
intraperitoneally
injected
either
SCFA
mixture
(acetate,
propionate,
butyrate)
or
PBS
for
period
7
days,
followed
by
infection.
All
observed
onset
progression
symptoms.
The
brain
tissue
was
collected
upon
reaching
terminal
illness
further
analysis.
SCFA-supplemented
JEV-infected
(SCFA
+
JEV)
showed
delayed
symptoms,
lower
hindlimb
clasping
score,
decreased
weight
loss
increased
survival
3
days
(p
<
0.0001)
infection
as
opposed
PBS-treated
animals
(JEV).
Significant
downregulation
cytokines
TNF-α,
MCP-1,
IL-6,
IFN-Υ
group
relative
control
observed.
Inflammatory
mediators,
phospho-NF-kB
(P-NF-kB)
iba1,
2.08
±
0.1
3.132
0.43-fold
upregulation
versus
1.19
0.11
1.31
0.11-fold
group,
respectively.
Tissue
section
analysis
exhibited
reduced
glial
activation
(JEV
group─42
2.15
microglia/ROI;
group─27.07
1.8
microglia/ROI)
received
supplementation
prior
seen
from
astrocytic
microglial
morphometric
Caspase-3
immunoblotting
4.08
1.3-fold
compared
1.03
0.14-fold
TUNEL
assay
cellular
death
post-JEV
(JEV-6.4
1.5
cells/ROI
JEV-3.7
0.73
cells/ROI).
Our
study
critically
contributes
increasing
evidence
support
an
agent,
expand
its
scope
supplementary
intervention
JEV-mediated
neuroinflammation.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(24), С. 17432 - 17432
Опубликована: Дек. 13, 2023
Autism
spectrum
disorder
(ASD)
is
a
complex
neurodevelopmental
condition
characterized
by
deficits
in
communication
and
social
interactions,
restrictive
repetitive
behavior,
wide
range
of
cognitive
impediments.
The
prevalence
ASD
tripled
the
last
20
years
now
affects
1
44
children.
Although
ASD's
etiology
not
yet
elucidated,
growing
body
evidence
shows
that
it
stems
from
interplay
genetic
environmental
factors.
In
recent
years,
there
has
been
increased
focus
on
role
gut
microbiota
their
metabolites,
as
studies
show
patients
significant
shift
composition,
an
increase
specific
bacteria
elevated
levels
short-chain
fatty
acids
(SCFAs),
especially
propionic
acid
(PPA).
This
review
aims
to
provide
overview
SCFAs
human
body,
well
possible
implications
shift.
Also,
highlights
current
aiming
compare
composition
microbiome
ASD-afflicted
with
neurotypical
control.
Finally,
rodents
where
ASD-like
symptoms
or
molecular
hallmarks
are
evoked,
via
grafting
microbes
obtained
subjects
direct
exposure
PPA.
International Journal of Alzheimer s Disease,
Год журнала:
2024,
Номер
2024(1)
Опубликована: Янв. 1, 2024
Recent
studies
strongly
suggest
that
gut
microbiome
can
influence
brain
functions
and
contribute
to
the
development
of
Alzheimer’s
disease
(AD).
However,
reported
changes
in
microbiomes
AD
patients
from
different
countries
are
not
similar,
more
research
is
needed
reveal
relationships
between
human
diverse
ethnic
populations.
There
also
an
assumption
microbiome‐associated
peripheral
inflammation
might
drive
sporadic
AD.
This
cross‐sectional
study
aimed
at
analyzing
microbial
profile
exploring
potential
associations
with
blood
cytokines
some
clinical
parameters
among
individuals
diagnosed
Kazakhstan.
Consistent
previous
studies,
we
have
found
landscape
reveals
specific
alterations
microbiome.
Specifically,
patient
group
showed
a
decreased
Firmicutes/Bacteroidetes
ratio.
The
differential
abundance
analysis
highlighted
dysbiosis
microbiota
patients,
marked
by
reduced
presence
Bifidobacterium
,
particularly
B.
breve
.
In
our
study,
patients’
altered
composition
notably
features
increased
Pseudomonadota
like
Phyllobacterium
inflammatory
bacteria
such
as
Synergistetes
Christensenellaceae
family.
metabolic
profiling
predominant
pathways
related
sugar,
carrier
molecules,
tetrapyrrole,
pyrimidine
biosynthesis,
nucleic
acid
processing.
reduction
SCFA,
carbohydrate,
polysaccharide,
polyamine,
myo‐inositol
degradation
pathways.
increases
proinflammatory
IL‐1a,
IL‐8,
IL‐17A,
IL‐12p40,
TNF‐
β
MCP‐1,
IL‐2,
IL‐12p70
anti‐inflammatory
IL‐10
IL‐13
were
observed
patients.
Key
variables
driving
separation
controls
include
markers
(IL‐1a
IL‐8),
growth
factors
(EGF),
lipids
(LDL),
BMI,
microbes,
genus
Tyzzerella
Turicibacter
species
Parabacteroides
distasonis
Bacteroides
eggerthii
We
demonstrated
almost
all
correlate
serum
adiponectin
levels
taxa
Thus,
findings
identify
signatures
ethnically
distinct
cohort
These
could
serve
biomarkers
microbiota‐based
therapeutic
targets
for
treating
Journal of Ayurveda and Integrative Medicine,
Год журнала:
2025,
Номер
16(1), С. 101041 - 101041
Опубликована: Янв. 1, 2025
Multi-targeted
drug
therapy
has
received
substantial
attention
for
the
treatment
of
diseases
multi-factorial
origin,
including
neurodegenerative
and
autoimmune
diseases.
It
seems
reasonable
to
argue
that
complex
pathology
(ND)
cannot
be
reduced
a
single
target
modulate
broad
range
cellular
signaling,
associated
pathologies,
symptoms.
is
this
idea
brought
scientific
world
towards
phytochemicals
traditional
drugs
are
notoriously
multi-targeted.
A
systematic
study
these
formulations
establishing
molecular
pathways
individual
molecules
can
lead
standardized
multi-component
product
activities
on
different
targets
ND.
This
could
provide
an
accessible
affordable
solution
significant
disease
burden
With
in
mind,
review
was
carried
out
Ayurvedic
Manasamitra
Vatakam
(MMV),
known
neuroprotective
formulation
highly
effective
against
Alzheimer's
disease.
MMV
source
phytomolecules
treating
The
multifactorial
nature
makes
them
suitable
candidates
testing
due
inherent
multitargeting
capabilities
compounds.
primary
objective
comprehensive
understanding
from
responsible
its
multitargeted
effect
From
reported
literature,
it
clear
many
phytoconstituents
extracts
herbal
ingredients
have
demonstrated
their
efficacy
AD
models.
However,
combination
models
never
been
tested.
Scientific
studies
should
done
explore
bioactive
compounds
druggability
identified
evaluated
using
experimental
methods.